In contrast, Lin et al. characterize FABP1 as a tumour suppressor in HCC, where its downregulation—frequently observed in tumour tissues compared to adjacent non-tumourous liver—was associated with reduced lipid accumulation and poorer patient survival. This evidence concerns the gene FABP1 and hepatocellular carcinoma.